远端胰腺切除联合腹腔干整块切除626例临床问题管理经验
BACKGROUND: Distal pancreatectomy with en bloc coeliac axis resection (DP-CAR) for pancreatic body cancer has been reported increasingly. However, its large-scale outcomes remain undocumented.…
要点
- DP-CAR可在普通胰腺外科中心安全开展,与DP-CAR手术量无关。
- 术前动脉栓塞可能不需要,且与缺血性胃病发生率升高相关。
- 对于靠近脾动脉与腹腔干分叉的可切除肿瘤,DP-CAR无肿瘤学优势。
核心结论
- DP-CAR可在普通胰腺外科中心安全开展, regardless of DP-CAR volume。
- 术前栓塞可能不需要。
- 对于靠近脾动脉分叉的可切除肿瘤,DP-CAR无肿瘤学优势,应经适当患者选择后施行。
研究设计与样本
- 多机构回顾性分析,纳入626例DP-CAR,并与同期1325例远端胰腺切除进行比较。
- 采用倾向性评分匹配分析比较DP-CAR与DP的肿瘤学获益。
- 分析DP-CAR手术量与死亡率、术前动脉栓塞与缺血性胃病的关系,以及预后因素。
主要发现
- 缺血性胃病发生率在栓塞组为19.2%,未栓塞组为7.9%(OR 2.77,95%CI 1.48-5.19)。
- 倾向性评分匹配后,DP-CAR组中位总生存33.5个月(95%CI 27.4-42.0),DP组37.9个月(95%CI 32.8-53.3)。
- 多变量分析确定年龄≥67岁(HR 1.40,95%CI 1.12-1.75)、术前肿瘤大小≥30 mm(HR 1.42,95%CI 1.12-1.80)和术前CA19-9>37 U/ml(HR 1.43,95%CI 1.11-1.83)为不良预后因素。
关键数值与推荐
- 缺血性胃病栓塞组19.2% vs 未栓塞组7.9%(OR 2.77,95%CI 1.48-5.19)。
- 倾向性评分匹配后中位总生存DP-CAR组33.5个月(95%CI 27.4-42.0),DP组37.9个月(95%CI 32.8-53.3)。
- 不良预后因素:年龄≥67岁(HR 1.40,95%CI 1.12-1.75)、肿瘤≥30 mm(HR 1.42,95%CI 1.12-1.80)、CA19-9>37 U/ml(HR 1.43,95%CI 1.11-1.83)。
临床怎么用
- DP-CAR可在普通胰腺外科中心开展,无需考虑DP-CAR手术量。
- 术前动脉栓塞可能不需要,以避免增加缺血性胃病风险。
- 对于靠近脾动脉与腹腔干分叉的可切除肿瘤,应优先考虑远端胰腺切除而非DP-CAR。
- 根据年龄、肿瘤大小和CA19-9水平进行患者选择。
局限性
- 回顾性多机构分析,可能存在选择偏倚和信息偏倚。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Distal pancreatectomy with en bloc coeliac axis resection (DP-CAR) for pancreatic body cancer has been reported increasingly. However, its large-scale outcomes remain undocumented. This study aimed to evaluate DP-CAR volume and mortality, preoperative arterial embolization for ischaemic gastropathy, the oncological benefit for resectable tumours close to the bifurcation of the splenic artery and coeliac artery using propensity score matching, and prognostic factors in DP-CAR. METHODS: In a multi-institutional analysis, 626 DP-CARs were analysed retrospectively and compared with 1325 distal pancreatectomies undertaken in the same interval. RESULTS: Ninety-day mortality was observed in 7 of 21 high-volume centres (1 or more DP-CARs per year) and 1 of 41 low-volume centres (OR 20.00, 95 per cent c.i. 2.26 to 177.26). The incidence of ischaemic gastropathy was 19.2 per cent in the embolization group and 7.9 per cent in the no-embolization group (OR 2.77, 1.48 to 5.19). Propensity score matching analysis showed that median overall survival was 33.5 (95 per cent c.i. 27.4 to 42.0) months in the DP-CAR and 37.9 (32.8 to 53.3) months in the DP group. Multivariable analysis identified age at least 67 years (HR 1.40, 95 per cent c.i. 1.12 to 1.75), preoperative tumour size 30 mm or more (HR 1.42, 1.12 to 1.80), and preoperative carbohydrate antigen 19-9 level over 37 units/ml (HR 1.43, 1.11 to 1.83) as adverse prognostic factors. CONCLUSION: DP-CAR can be performed safely in centres for general pancreatic surgery regardless of DP-CAR volume, and preoperative embolization may not be required. This procedure has no oncological advantage for resectable tumour close to the bifurcation of the splenic artery, and should be performed after appropriate patient selection.
引用
- Nakamura T, Okada KI, Ohtsuka M, et al. Insights from managing clinical issues in distal pancreatectomy with en bloc coeliac axis resection: experiences from 626 patients. Br J Surg. 2023. PMID: 37469172. doi:10.1093/bjs/znad212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。